Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Study focuses on elevation of amylase and lipase levels as predictors of pancreatitis.
Read More »Liraglutide and Acute Pancreatitis in Patients With Type 2 Diabetes
Liraglutide Reduces Liver Fat Content in Patients With Poorly Controlled Type 2 Diabetes
A proposed benefit of GLP-1 agonists confirmed in a human study.
Read More »AACE: Complete Reversal of Type 2 Diabetes With GLP-1 Agonist
Retrospective analysis presentation shows liraglutide (LIRA) improved glycemic parameters, reduced body weight, BMI, and waist circumference in new T2 patients.
Read More »AACE: Fourth Complication From Type 2 Diabetes: Heart Failure
More rigorous screening called for to mitigate poor outcomes of this common condition.
Read More »Importance of GI Events for GLP-1 Receptor Agonists
Study finds fewer T2 patients on exenatide once-weekly reported gastrointestinal adverse events, compared with those on exenatide twice-daily or liraglutide once-daily.
Read More »Children, Adolescents With Diabetes Might Be Missing Out on Retinopathy Screenings
Race, socioeconomic status thought reasons behind lack of adherence to the recommendations.
Read More »A Major Shift in Diabetes Treatment Targets and Goals
Out with the old, in with the old and new?
Read More »Diet and Diabetes Risk
Are beans really the magical fruit?
Read More »SLGT-2 Inhibitors Gaining Traction as a Class in Preventing Cardiovascular Consequences
Are we experiencing the next “magic bullet” in type 2 diabetes?
Read More »DKA Not Associated With SGLT-2 inhibitors
Study reported SGLT2 Inhibitors monotherapy might not lead to DKA events as opposed to insulin therapy.
Read More »